Genevieve Deblois

Principal Investigator at IRIC and Assistant Professor at University of Montreal - Faculty of Pharmacy

Montreal, Quebec, Canada

About

• Innovative researcher with expertise in cancer epigenetics, genome integrity, computer biology, functional genomics, molecular biology, cancer drug response, cancer metabolism, pharmacology, and cancer immunology. • Experienced in leading cancer research projects, budget management, writing grants and reports, scientific communication, supervision of trainees. • Contributed to 24 scientific research publications. • Strong communication skills: 34 posters and 13 selected oral presentations (15 awards). • Experienced in managing multidisciplinary teams and projects linking epigenetics, metabolomics, immunology, clinical, and bioinformatics. • Organized, multitask and efficient team player. • Fluent in French (native) and English.

Experience

  • Principal Investigator at Institut de recherche en immunologie et en cancérologie (IRIC)
    Mar 2020 - Present · 6 yrs 5 mos

  • Assistant Professor at Faculté de pharmacie - UdeM
    Mar 2020 - Present · 6 yrs 5 mos

  • Post doctoral fellow at Princess Margaret Cancer Centre at University Health Network
    May 2014 - Present · 12 yrs 3 mos

    Princess Margaret Cancer Research Center, UHN, Toronto, Laboratory of Dr. Mathieu Lupien Goodman Cancer Research Center, Montréal, Laboratory of Dr. Morag Park, (visiting Postdoc) Functional epigenomic and metabolomic research in chemoresistant breast cancer Fellowships: Cancer Research Society Next Generation of Scientists Scholarship (2018-2021) CIHR: Post-doctoral fellowship (2014-2017) FRSQ post-doctoral fellowship (2014-2017, cumulated with CIHR) Scientific accomplishments: • Initiated an independent project implementing a novel theme to study the role of cancer metabolism in the control of tumor epigenetics in the Lupien lab. • Uncovered an epigenetic compensatory mechanism identifying a targetable histone modification vulnerability with clinical applications in drug-resistant breast cancer. • Established successful collaborations with experts in epigenetics, bioinformatics, oncology, pharmacology, cancer drug discovery, drug resistance, metabolism, and medical imaging. • Contributed to 6 publications: 2 first-authored and 3 collaborative publications, one book chapter, participation at international conferences: 11 posters, 3 poster prizes, 6 oral presentations. • Supervised 4 summer students, 5 undergraduate students and mentored 2 Ph.D. students.

  • PhD Candidate, Biochemistry at McGill University
    Jan 2008 - Nov 2013 · 5 yrs 11 mos

    Goodman Cancer Research Centre, McGill University, Biochemistry, Montréal, Laboratory of Dr. Vincent Giguère Functional genomic analyses of nuclear receptor transcriptional profiles Scientific accomplishments: • Characterized a therapeutically targetable factor driving poor prognosis in breast cancer. • Implemented several state-of-the-art technologies in functional genomics in the Giguère lab. • Contributed to 13 publications, including 8 first author publications (4 reviews). • Participated to international conferences: 16 posters, 9 poster prizes, 4 selected oral presentations. • Recipient of several Ph.D. studentships and prestigious prizes including the General Governor's Gold Medal and the Marylin Wener award of excellence (see Awards section for complete list)

  • Research Assistant, cancer genomics project, McGill University Health Centre (MUHC) at Centre universitaire de santé McGill et IR-CUSM | McGill University Health Centre and RI-MUHC
    Nov 2005 - Jan 2008 · 2 yrs 3 mos

    Deciphering nuclear receptors transcriptional profiles in breast cancer • Designed, led and accomplished several independent research projects in genomics • Contributed to several Ph.D and postdoctoral research projects • Developed and optimized genomic techniques in the laboratory • Collaborated with a multidisciplinary research groups (genomics and bioinformatics) • Contributed to 3 scientific publications • Recruit and supervised technicians